Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia. | Front Immunol | 2023 | 37266435 | PubTator, text mining | PubMed |
| Regulation of EBNA1 protein stability and DNA replication activity by PLOD1 lysine hydroxylase. | PLoS Pathog | 2023 | 37262099 | PubTator, text mining | PubMed |
| A risk signature of ubiquitin-specific protease family predict the prognosis and therapy of kidney cancer patients. | BMC Nephrol | 2023 | 37259026 | PubTator, text mining | PubMed |
| USP7 regulates HMOX-1 via deubiquitination to suppress ferroptosis and ameliorate spinal cord injury in rats. | Neurochem Int | 2023 | 37257587 | PubTator, text mining | PubMed |
| A review of deubiquitinases and thier roles in tumorigenesis and development. | Front Bioeng Biotechnol | 2023 | 37251574 | PubTator, text mining | PubMed |
Ubiquitin-specific protease 7 prevents recurrent spontaneous abortion by targeting enhancer of zeste homolog 2 to regulate trophoblast proliferation, apoptosis, migration, and invasion through the Wnt/β-catenin pathway†. | Biol Reprod | 2023 | 37249558 | PubTator, text mining | PubMed |
| p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act. | Nutrients | 2023 | 37242146 | PubTator, text mining | PubMed |
| The deubiquitinase USP28 maintains the expression of the transcription factor MYCN and is essential in neuroblastoma cells. | J Biol Chem | 2023 | 37230388 | PubTator, text mining | PubMed |
| The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases. | MedComm (2020) | 2023 | 37229485 | PubTator, text mining | PubMed |
| The role of regulators of RNA m6A methylation in lung cancer. | Genes Dis | 2023 | 37223516 | PubTator, text mining | PubMed |
| S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy. | Breast Cancer Res | 2023 | 37217945 | PubTator, text mining | PubMed |
| The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy. | Front Immunol | 2023 | 37215134 | PubTator, text mining | PubMed |
| Regulatory mechanisms and clinical applications of tumor-driven exosomal circRNAs in cancers. | Int J Med Sci | 2023 | 37213665 | PubTator, text mining | PubMed |
| USP7 Inhibits Osteoclastogenesis via Dual Effects of Attenuating TRAF6/TAK1 Axis and Stimulating STING Signaling. | Aging Dis | 2023 | 37199589 | PubTator, text mining | PubMed |
| USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities. | Sci Adv | 2023 | 37196079 | PubTator, text mining | PubMed |
| Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators. | Aging Dis | 2023 | 37191431 | PubTator, text mining | PubMed |
| The Ubiquitin-Proteasome System in Tumor Metabolism. | Cancers (Basel) | 2023 | 37190313 | PubTator, text mining | PubMed |
| USP8 Down-Regulation Promotes Parkin-Independent Mitophagy in the Drosophila Brain and in Human Neurons. | Cells | 2023 | 37190052 | PubTator, text mining | PubMed |
| MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis. | Int J Gen Med | 2023 | 37181643 | PubTator, text mining | PubMed |
| Molecular Target and Action Mechanism of Anti-Cancer Agents. | Int J Mol Sci | 2023 | 37175963 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=33